Olink Holding AB (publ) - ADR

Great News! Now you can buy fractional shares of Olink Holding AB (publ) - ADR

What is Fractional Shares?

Fractional shares are pieces of one full share of a company or exchange-traded fund (ETF).

In INDmoney, you can buy Olink Holding AB (publ) - ADR stock in any dollar amount, or any other stock you want.

$10

$50

$100

OLK

Olink Holding AB (publ) - ADR (OLK)

Q: What is Olink Holding AB (publ) - ADR (OLK) share price today?

Olink Holding AB (publ) - ADR (OLK) share price today is $14.34

Q: Can Indians buy Olink Holding AB (publ) - ADR (OLK) shares?

Yes, Indians can buy Olink Holding AB (publ) - ADR (OLK) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy Olink Holding AB (publ) - ADR (OLK) shares from India?

Three ways to invest in Olink Holding AB (publ) - ADR (OLK) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in Olink Holding AB (publ) - ADR (OLK) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of Olink Holding AB (publ) - ADR (OLK) be purchased?

You can buy just a fraction of Olink Holding AB (publ) - ADR (OLK) shares.

Q: What are the documents required to start investing in Olink Holding AB (publ) - ADR (OLK) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in Olink Holding AB (publ) - ADR (OLK) stocks . The entire process is paperless and can be completed seamlessly.

$14.345.22%▲

Key Stats

Open	$14.87
Today Low/High	$14.14 / $14.97
52 Week Low/High	$10.64 / $42.2
Market Cap	$1.55B

Company Details

Olink Holding AB (publ) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.